NL7301923A - - Google Patents

Info

Publication number
NL7301923A
NL7301923A NL7301923A NL7301923A NL7301923A NL 7301923 A NL7301923 A NL 7301923A NL 7301923 A NL7301923 A NL 7301923A NL 7301923 A NL7301923 A NL 7301923A NL 7301923 A NL7301923 A NL 7301923A
Authority
NL
Netherlands
Application number
NL7301923A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7301923A publication Critical patent/NL7301923A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7301923A 1972-02-11 1973-02-09 NL7301923A (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722207422 DE2207422A1 (de) 1972-02-11 1972-02-11 15alpha, 16alpha-methylen-5alpha-androstane

Publications (1)

Publication Number Publication Date
NL7301923A true NL7301923A (hr) 1973-08-14

Family

ID=5836212

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7301923A NL7301923A (hr) 1972-02-11 1973-02-09

Country Status (9)

Country Link
JP (1) JPS4886855A (hr)
AT (1) AT323345B (hr)
BE (1) BE795239A (hr)
CH (1) CH588506A5 (hr)
DE (1) DE2207422A1 (hr)
DK (1) DK130988B (hr)
FR (1) FR2181720B1 (hr)
GB (1) GB1426353A (hr)
NL (1) NL7301923A (hr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643035B2 (de) * 1967-08-11 1976-01-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 15beta,16beta-methylen-5alpha -androst-l-ene, verfahren zu deren herstellung sowie diese enthaltende mittel

Also Published As

Publication number Publication date
DK130988C (hr) 1975-10-13
GB1426353A (en) 1976-02-25
DK130988B (da) 1975-05-12
JPS4886855A (hr) 1973-11-15
DE2207422A1 (de) 1973-08-16
CH588506A5 (hr) 1977-06-15
BE795239A (fr) 1973-08-09
FR2181720A1 (hr) 1973-12-07
FR2181720B1 (hr) 1975-11-21
AT323345B (de) 1975-07-10

Similar Documents

Publication Publication Date Title
JPS5723761Y2 (hr)
JPS4983137A (hr)
JPS499362U (hr)
JPS536623B2 (hr)
DK130988C (hr)
JPS4988088U (hr)
JPS4983773U (hr)
CH565246A5 (hr)
CH576131A5 (hr)
CH570340A5 (hr)
AU936672A (hr)
BE791264A (hr)
BG17911A1 (hr)
CH565301A5 (hr)
CH441173A4 (hr)
CH560410A (hr)
CH561486A5 (hr)
CH561670A5 (hr)
CH563553A5 (hr)
CH563676A5 (hr)
CH563766A5 (hr)
CH564946A5 (hr)
CH564948A5 (hr)
CH564974A5 (hr)
CH567900A5 (hr)

Legal Events

Date Code Title Description
BV The patent application has lapsed